摘要
目的研究^18F—FDGPET/CT在心脏肿瘤诊断中的临床应用价值。方法自2007年1月至2011年12月行全身^18F—FDGPET/CT检查的8649例受检者中,诊断为心脏肿瘤者r与0.16%(14/8649)。对这14例患者进行叫顾性分析,其中男11例,女3例;年龄46.9(35~68)岁。患者最终诊断以外科手术病理结果(5例)、肿瘤病史和临床随访结果(9例)为依据,分析^18F—FDGPET/CT诊断情况。结果14例心脏肿瘤,^18F—FDGPET/CT均作出准确定位和定性诊断。其中,转移性肿瘤11例,占78.6%(11/14);原发恶性肿瘤2例,占14.3%(2/14);原发良性黏液瘤l例,占7.1%(1/14)。11例转移性肿瘤的原发肿瘤分别为HCC(8例),肺癌(2例)和食管癌(1例)。2例原发恶性肿瘤均发生转移。13例恶性肿瘤患者SUVmax、为3.2~10.7,高于正常心肌。结论全身^18F—FDG PEF/CT检查对心脏转移及原发肿瘤诊断有重要价值,可探查心脏恶性肿瘤全身转移情况,从而进行准确分期,指导临床治疗。
Objective To explore the clinical value of 18F-FDG PET/CT in the diagnosis of cardiac neoplasm. Methods Between January 2007 and December 2011, ^18F-FDC PET/CT was performed in 8649 patients in our hospital, and 14 (0.16% : 11 males, 3 females, average age 46.9 (35 -68) years) patients were diagnosed with cardiac neoplasm. ^18F-FDG PET/CT data of those 14 patients were retrospectively analyzed. Final diagnoses were eonfirmed by either histopathology (n = 5 ) or follow-up (n =9). Results Accurate tumor localization and diagnoses were made by ^18F-FDG PET/CT in all 14 patients. Among them, 13 were malignant (2 ( 14.3% , 2/14) primary and 11 (78.6% , 11/14) metastatic tumors ( 8 HCC, 2 lung caneer, 1 esophageal cancer) ; SUVmax 3.2 - 10.7) and 1 (7.1%, 1/14) was benign (myxoma). Conclusion ^18F-FDG PET/CT is usefid for the detection and staging of primary malignant and metastatic cardiac neoplasms.
出处
《中华核医学与分子影像杂志》
CSCD
北大核心
2013年第3期175-178,共4页
Chinese Journal of Nuclear Medicine and Molecular Imaging
基金
国家自然科学基金(81101067)